Back to search
FDAFDA · Food and drugs·Recall number D-0969-2015

0.9% Sodium Chloride Injection, USP, 250 mL, Rx Only, Hospira Inc., Lake Forest, IL, 60045, USA, NDC 0409-7983-02

Published April 29, 2015 · Recall initiated: January 20, 2015

Summary

FDA records drug Class I recall D-0969-2015, published April 29, 2015 and initiated January 20, 2015. Recalling firm: Hospira Inc.; Status: Terminated; Reported quantity: 661,128 containers; Lot: Lot #: 44-002-JT (the lot number may be followed by 01 to 99), Exp 08/01/2016. Class I means a reasonable probability of serious adverse health consequences or death.

Status when published: Terminated — openFDA updates weekly, so this field may not reflect the current status. Always confirm with the official notice.

What's the hazard

Presence of Particulate Matter; Hospira has identified the particulate as a human hair, sealed in the bag at the additive port area.

What to do

Voluntary: Firm initiated · Press Release

Get an email when a new FDA recall like this is published

Free. We only write when there's a new recall that matches. Unsubscribe in one click.

Recall details

Manufacturer
Hospira Inc.
Distributor
Nationwide
Lot
Lot #: 44-002-JT (the lot number may be followed by 01 to 99), Exp 08/01/2016
Risk classification
Class I
Area (FDA)
drug
Country
United States

Related recalls

Questions about this recall

Was 0.9% Sodium Chloride Injection, USP, 250 mL, Rx Only, Hospira Inc., Lake Forest, IL, 60045, USA, NDC 0409-7983-02 recalled?

Yes. FDA published recall D-0969-2015 on April 29, 2015. Reported hazard: Presence of Particulate Matter; Hospira has identified the particulate as a human hair, sealed in the bag at the additive port area.

What should I do if I have this product?

Voluntary: Firm initiated · Press Release